Last Updated 1 July 2022.
11 Vaccines Approved for Use in India
-
Biological E Limited
Corbevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 5 countries
3 trials in 1 country
-
Zydus Cadila
ZyCoV-D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Gennova Biopharmaceuticals Limited
GEMCOVAC-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
67 trials in 23 countries
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 26 countries
7 trials in 3 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
25 trials in 8 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
24 trials in 24 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
66 trials in 31 countries
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
4 trials in 1 country
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
14 trials in 2 countries
16 Vaccines in Clinical Trials in India
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
17 trials in 13 countries
-
Biological E Limited
Corbevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 5 countries
3 trials in 1 country
-
University Medical Center Groningen
AKS-452- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 2 countries
-
Zydus Cadila
ZyCoV-D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Gennova Biopharmaceuticals Limited
GEMCOVAC-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Bharat Biotech
BBV154- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 1 country
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 26 countries
7 trials in 3 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
25 trials in 8 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
66 trials in 31 countries
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
4 trials in 1 country
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
14 trials in 2 countries
-
Biological E Limited
BECOV2B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2C- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Gennova Biopharmaceuticals Limited
HGCO19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country